First elected: 7th June 2001
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Mark Francois, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Mark Francois has not been granted any Urgent Questions
Mark Francois has not been granted any Adjournment Debates
A Bill to make provision about the regulation of roadworks; and for connected purposes.
A Bill to set penalties for overrunning roadworks; to make requirements regarding the duration, timing and coordination of roadworks; and for connected purposes.
Senior Civil Service (Accountability and Appointment) Bill 2023-24
Sponsor - Giles Watling (Con)
Assistance Dogs and Pavement Parking Bill 2023-24
Sponsor - Bill Wiggin (Con)
NHS Prescriptions (Drug Tariff Labelling) Bill 2022-23
Sponsor - Lord Mackinlay of Richborough (Con)
Automated External Defibrillators (Housing Developments) Bill 2022-23
Sponsor - Stephen Metcalfe (Con)
Sale of Property (Sealed Bids) Bill 2022-23
Sponsor - Bill Wiggin (Con)
House of Commons (Precedence of Government Business) (European Union (Withdrawal) Act 2018)
Sponsor - William Cash (Con)
Armed Forces (Derogation from European Convention on Human Rights) Bill 2017-19
Sponsor - Leo Docherty (Con)
NHS England has implemented non-symptom specific pathways for patients who present with symptoms that can indicate several different cancers, including leukaemia. An NHS England national evaluation showed blood cancers are one of the most common cancer types diagnosed through these pathways.
Raising awareness, delivering more research, including into new treatments, and improving early diagnosis of cancers, which includes blood related cancers such as leukaemia, are crucial for improving cancer survival.
NHS England has implemented non-symptom specific pathways for patients who present with non-specific symptoms, or combinations thereof, that can indicate several different cancers. This includes leukaemia, which can present non-specific symptoms, such as unexpected weight loss and night sweats. Using its national evaluation, NHS England has determined that blood cancers are one of the most common cancer types diagnosed through these pathways.
Professor Lord Darzi is currently undertaking an independent investigation into the state of the National Health Service, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will set out any further priorities on cancer and health in due course.
The NHS Long-Term Plan, published in January 2019, sets out the NHS’s key ambitions on cancer. The plan sets out the ambition to increase the number of cancers diagnosed at stage one and two to 75% by 2028, and to increase the number of people surviving cancer for five years by 55,000 as a result.
The age-standardised, one-year net survival for adults, those aged 15 to 99 years old, diagnosed with leukaemia between 2016 and 2020 in England was 74.4%, and the five-year survival rate was 55.9%.
NHS England has implemented non symptom specific pathways for patients who present with non-specific symptoms or combinations thereof, that can indicate several different cancers. This includes leukaemia, which can present non-specific symptoms, such as unexpected weight loss and night sweats. The national evaluation showed that blood cancers are one of the most common cancer types diagnosed through these pathways.
Raising awareness, delivering more research, including into new treatments, and improving early diagnosis of cancers, which includes blood related cancers such as leukaemia, are crucial for improving cancer survival.
Cancer patients are being failed, waiting too long for a diagnosis and treatment. We will bring down waits for cancer appointments with the Fit For the Future fund, doubling the number of state-of-the-art magnetic resonance imaging and computed tomography in the National Health Service to ensure early diagnosis and faster treatment.
NHS England has committed to ensuring that all cancer patients have access to a Holistic Needs Assessment, ensuring care is focused on what matters most to each person.
The 2023 England National Cancer Patient Experience Survey indicates the proportion of people with Leukaemia who reported having had a discussion with a member of the team looking after them, before their treatment started, about their needs or concerns was 72.6%. For people with Leukaemia, a further 24.5% said they had the discussion to some extent, and a total of 97.1% reported having had a discussion.